Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Essa Pharma
Biotech
Investor pressures Essa to liquidate, give cash to shareholders
Soleus, one of the biotech's top shareholders, put the proposal to Essa’s board after concluding that the best option is to return cash to investors.
Nick Paul Taylor
Apr 16, 2025 8:04am
Essa drops lead cancer drug after falling short against Xtandi
Nov 1, 2024 7:33am
Janssen can't conjure up patients for ESSA prostate cancer trial
Oct 31, 2022 10:20am
Pfizer invests $120M in 4 biotechs through new growth fund
Jan 12, 2021 8:55am
Essa to buy Realm, gaining cash to fund cancer R&D
May 16, 2019 9:45am
